Abstract
Objective: Aseptic loosening is one of the most important problems that can occur after total hip arthroplasty (THA). In this study, we analysed levels of large tenascin‐C (TN‐C) variants and compared them in pseudosynovial fluid from patients with aseptic loosening after THA with those in synovial fluid from patients undergoing primary THA (control).Methods: Pseudosynovial fluid samples (n = 24) were obtained by aspiration at the time of revision THA performed due to aseptic loosening. Synovial fluid samples (n = 12) were obtained by aspiration at the time of primary THA. Expression of TN‐C splice variants was examined using immunoblotting. TN‐C levels were measured using an enzyme‐linked immunosorbent assay (ELISA) system that we developed previously.Results: Western blotting showed the presence of large TN‐C variants in pseudosynovial fluid of artificial joints with loosening. TN‐C levels were approximately three times higher in pseudosynovial fluid of loose artificial joints (median 151.9 ng/mL) than in synovial fluid controls (median 50.1 ng/mL) (p = 0.035).Conclusion: Levels of TN‐C including large variant subunits are elevated in pseudosynovial fluid of loose artificial joints, indicating that TN‐C is a useful novel biochemical marker of loose hip prostheses.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
